Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1998-03-21
1999-11-09
McKane, Joseph K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514424, 514429, 514617, A61K 3140, C07D20704
Patent
active
059815132
ABSTRACT:
Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics and anti-pruritic agents are provided. The compounds of formula II having the structure: ##STR1## wherein X.sub.4, X.sub.5 ;
REFERENCES:
patent: 4065573 (1977-12-01), Lednicer
patent: 4098904 (1978-07-01), Szmuszkovicz
patent: 4145435 (1979-03-01), Szmuskovicz
patent: 4212878 (1980-07-01), Lednicer et al.
patent: 4359476 (1982-11-01), Kaplan et al.
patent: 4438130 (1984-03-01), Kaplan
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5646151 (1997-07-01), Kruse et al.
patent: 5688955 (1997-11-01), Kruse et al.
patent: 5744458 (1998-04-01), Kruse et al.
McMahon et al., TINS, vol. 15, No. 12 (1992).
Bernstein et al., Journal of Investigative Dermatology, 78: 82-83 (1982).
Ballantyne et al., Pain, 33:149-160 (1988).
J. D. Bernhard, J. Am. Acad. Derm. 24: 309 (1991).
IASP Newsletter, Sep./Oct. 1996.
Thomas et al., Brain Research, 695: 267-270 (1995).
Chang An-Chih
DeHaven-Hudkins Diane L.
Farrar John J.
Gaul Forrest
Kruse Lawrence I.
Adolor Corporation
Balogh Imre
McKane Joseph K.
LandOfFree
Kappa agonist compounds, pharmaceutical formulations and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa agonist compounds, pharmaceutical formulations and method , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa agonist compounds, pharmaceutical formulations and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456127